EP0698398A1 — Blood collection device
Assigned to Becton Dickinson and Co · Expires 1996-02-28 · 30y expired
What this patent protects
A blood collection device comprising an anticoagulant formulation on the interior surface of the device. The anticoagulant formulation on the interior surface of the device is an improvement over available devices that contain liquid anticoagulant formulations. The device is coat…
USPTO Abstract
A blood collection device comprising an anticoagulant formulation on the interior surface of the device. The anticoagulant formulation on the interior surface of the device is an improvement over available devices that contain liquid anticoagulant formulations. The device is coated by combining sodium citrate and citric acid in a water vehicle, spraying the formulation onto the interior surface of the device, followed by air drying.
Drugs covered by this patent
- Heparin Sodium In Plastic Container (Heparin Sodium) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.